Peptides for SARS-CoV-19 Research
GenScript provides a full spectrum of high-quality peptide services ranging from Custom Peptide Synthesis (research and cGMP grade) to high-throughput to high-throughput Peptide Library and Peptide Array services. With access to the state-of-the-art equipment and experienced chemists using the latest technologies, we have delivered over 600,000 custom peptides to more than 10,000 scientists worldwide.
To meet the increasing demand for COVID-19 research, GenScript has developed a series of SARS-CoV-2 Peptide and Peptide Libraries based on GenScript's rich experience in peptide design and synthesis.
You can find the peptides as below, and more peptide services here.
|
Peptide |
Description |
|
MCP_0001569 (Biotin - Ahx) - SARS - CoV - 2 Spike RBM (receptor binding motif) |
This
peptide sequence has residues 438-458 obtained from the RBM (receptor binding
motif: 437-508) identified within the RBD from the RefSeq (YP_009724390.1) of
spike protein of SARS-CoV-2. The sequence is labeled with Biotin-Ahx at the
N-terminus. |
|
MCP_0001570 SARS - CoV - 2 Spike RBD (receptor binding domain), 319 - 335 |
This
peptide sequence represents residues 319-335 of the RBD (receptor binding
domain) identified from the RefSeq (YP_009724390.1) from the spike protein of
SARS-CoV-2. |
|
MCP_0001571 SARS - CoV - 2 Spike RBD (receptor binding domain), 319 - 335 - Lys(Biotin - Ahx) |
This
peptide sequence represents residues 319-335 of the RBD (receptor binding
domain) identified from the RefSeq (YP_009724390.1) from the spike protein of
SARS-CoV-2. The sequence is labeled with Biotin-Ahx at the C-terminus. |
|
MCP_0001572 SARS - CoV - 2 Spike RBD (receptor binding domain), 336 - 347 |
This
peptide sequence represents residues 336-347 of the RBD (receptor binding
domain) identified from the RefSeq (YP_009724390.1) from the spike protein of
SARS-CoV-2. |
|
MCP_0001573 SARS - CoV - 2 Spike RBD (receptor binding domain), 336 - 347 - Lys(Biotin - Ahx) |
This
peptide sequence represents residues 336-347 of the RBD (receptor binding
domain) identified from the RefSeq (YP_009724390.1) from the spike protein of
SARS-CoV-2. The sequence is labeled with Biotin-Ahx at the C-terminus. |
|
MCP_0001574 SARS - CoV - 2 Spike RBD (receptor binding domain), 348 - 357 |
This
peptide sequence represents residues 348-357 of the RBD (receptor binding
domain) identified from the RefSeq (YP_009724390.1) from the spike protein of
SARS-CoV-2. |
|
MCP_0001575 SARS - CoV - 2 Spike RBD (receptor binding domain), 348 - 357 - Lys(Biotin - Ahx) |
This
peptide sequence represents residues 348-357 of the RBD (receptor binding
domain) identified from the RefSeq (YP_009724390.1) from the spike protein of
SARS-CoV-2. The sequence is labeled with Biotin-Ahx at the C-terminus. |
|
MCP_0001576 SARS - CoV - 2 Spike RBD (receptor binding domain), 352 - 365 |
This
peptide sequence represents residues 352-365 of the RBD (receptor binding
domain) identified from the RefSeq (YP_009724390.1) from the spike protein of
SARS-CoV-2. |
|
MCP_0001577 SARS - CoV - 2 Spike RBD (receptor binding domain), 352 - 365 - Lys(Biotin - Ahx) |
This
peptide sequence represents residues 352-365 of the RBD (receptor binding
domain) identified from the RefSeq (YP_009724390.1) from the spike protein of
SARS-CoV-2. The sequence is labeled with Biotin-Ahx at the C-terminus. |
|
MCP_0001578 SARS - CoV - 2 Spike RBD (receptor binding domain), 371 - 394 |
This
peptide sequence represents residues 371-394 of the RBD (receptor binding
domain) identified from the RefSeq (YP_009724390.1) from the spike protein of
SARS-CoV-2. |
|
MCP_0001579 SARS - CoV - 2 Spike RBD (receptor binding domain), 371 - 394 - Lys(Biotin - Ahx) |
This
peptide sequence represents residues 371-394 of the RBD (receptor binding
domain) identified from the RefSeq (YP_009724390.1) from the spike protein of
SARS-CoV-2. The sequence is labeled with Biotin-Ahx at the C-terminus. |
|
MCP_0001580 SARS - CoV - 2 Spike RBD (receptor binding domain), 395 - 430 |
This
peptide sequence represents residues 395-430 of the RBD (receptor binding
domain) identified from the RefSeq (YP_009724390.1) from the spike protein of
SARS-CoV-2. |
|
MCP_0001581 SARS - CoV - 2 Spike RBD (receptor binding domain), 395 - 430 - Lys(Biotin - Ahx) |
This
peptide sequence represents residues 395-430 of the RBD (receptor binding
domain) identified from the RefSeq (YP_009724390.1) from the spike protein of
SARS-CoV-2. The sequence is labeled with Biotin-Ahx at the C-terminus. |
|
MCP_0001582 SARS - CoV - 2 Spike RBD (receptor binding domain), 513 - 520 |
This
peptide sequence represents residues 513-520 of the RBD (receptor binding
domain) identified from the RefSeq (YP_009724390.1) from the spike protein of
SARS-CoV-2 |
|
MCP_0001583 SARS - CoV - 2 Spike RBD (receptor binding domain), 513 - 520 - Lys(Biotin - Ahx) |
This
peptide sequence represents residues 513-520 of the RBD (receptor binding
domain) identified from the RefSeq (YP_009724390.1) from the spike protein of
SARS-CoV-2. The sequence is labeled with Biotin-Ahx at the C-terminus. |
|
MCP_0001584 SARS - CoV - 2 Spike RBD (receptor binding domain), 523 - 541 |
This
peptide sequence represents residues 523-541 of the RBD (receptor binding
domain) identified from the RefSeq (YP_009724390.1) from the spike protein of
SARS-CoV-2. |
|
MCP_0001585 SARS - CoV - 2 Spike RBD (receptor binding domain), 523 - 541 - Lys(Biotin - Ahx) |
This
peptide sequence represents residues 523-541 of the RBD (receptor binding
domain) identified from the RefSeq (YP_009724390.1) from the spike protein of
SARS-CoV-2. The sequence is labeled with Biotin-Ahx at the C-terminus. |
|
MCP_0001586 SARS - CoV - 2 Spike RBM (receptor binding motif), 438 - 458 |
This
peptide sequence has residues 438-458 obtained from the RBM (receptor binding
motif: 437-508) identified within the RBD from the RefSeq (YP_009724390.1) of
spike protein of SARS-CoV-2. |
|
MCP_0001587 SARS - CoV - 2 Spike RBM (receptor binding motif), 450 - 473 |
This
peptide sequence has residues 450-473 obtained from the RBM (receptor binding
motif: 437-508) identified within the RBD from the RefSeq (YP_009724390.1) of
spike protein of SARS-CoV-2. |
|
MCP_0001588 SARS - CoV - 2 Spike RBM (receptor binding motif), 450 - 473 - Lys(Biotin - Ahx) |
This
peptide sequence has residues 450-473 obtained from the RBM (receptor binding
motif: 437-508) identified within the RBD from the RefSeq (YP_009724390.1) of
spike protein of SARS-CoV-2. The sequence is labeled with Biotin-Ahx at the
C-terminus. |
|
MCP_0001589 SARS - CoV - 2 Spike RBM (receptor binding motif), 480 - 496 |
This
peptide sequence has residues 480-496 obtained from the RBM (receptor binding
motif: 437-508) identified within the RBD from the RefSeq (YP_009724390.1) of
spike protein of SARS-CoV-2. |
|
MCP_0001590 SARS - CoV - 2 Spike RBM (receptor binding motif), 480 - 496 - Lys(Biotin - Ahx) |
This
peptide sequence has residues 480-496 obtained from the RBM (receptor binding
motif: 437-508) identified within the RBD from the RefSeq (YP_009724390.1) of
spike protein of SARS-CoV-2. The sequence is labeled with Biotin-Ahx at the
C-terminus. |
|
MCP_0001591 SARS - CoV - 2 Spike RBM (receptor binding motif), 500 - 509 |
This
peptide sequence has residues 500-509 obtained from the RBM (receptor binding
motif: 437-508) identified within the RBD from the RefSeq (YP_009724390.1) of
spike protein of SARS-CoV-2. |
|
MCP_0001592 SARS - CoV - 2 Spike RBM (receptor binding motif), 500 - 509 - Lys(Biotin - Ahx) |
This
peptide sequence has residues 500-509 obtained from the RBM (receptor binding
motif: 437-508) identified within the RBD from the RefSeq (YP_009724390.1) of
spike protein of SARS-CoV-2. The sequence is labeled with Biotin-Ahx at the
C-terminus. |
|
MCP_0000053 |
An
ACE-2 (Angiotensin I-converting enzyme 2) fluorescent substrate. Complete
hydrolysis of 0.04 mM results in a 300-fold fluorescence increase over
background. Max Abs/Em=325/393 nm upon cleavage of substrate. |
|
MCP_0000359 |
A
potent inhibitor specific for ACE2. It has a Ki of 2.8 nM. |
- Like (7)
- Reply
-
Share
About Us · User Accounts and Benefits · Privacy Policy · Management Center · FAQs
© 2024 MolecularCloud